Etelcalcetide: Uses, Dosage, Side Effects and More | Your Complete Guide

Etelcalcetide is a newly developed pharmaceutical product by Hybio Pharmaceutical Co., Ltd. It is a novel calcimimetic agent that has been designed for the treatment of secondary hyperparathyroidism in adult patients with chronic kidney disease on hemodialysis. Etelcalcetide works by binding to and activating the calcium-sensing receptor on parathyroid chief cells, thereby reducing the secretion of parathyroid hormone, This innovative medication offers a new approach to managing secondary hyperparathyroidism, providing patients with a more effective treatment option. Clinical trials have shown promising results in terms of its ability to lower parathyroid hormone levels and maintain serum calcium concentrations within the target range, Hybio Pharmaceutical Co., Ltd. is committed to bringing high-quality and innovative pharmaceutical products to the market, and Etelcalcetide is a testament to this dedication. With its potential to improve the lives of patients with chronic kidney disease on hemodialysis, Etelcalcetide represents a significant advancement in the management of secondary hyperparathyroidism